Cognitive/Behavioral Neurologist I Clinical Research | Ethics | Alzheimer Disease | Equity in Brain Health | Brigham and Womens @BWHNeurology @HarvardMed
Alzheimer disease starts well before any symptoms. The ways we fully understand this and characterize asymptomatic individuals is emerging in the clinic and in society. A commentary. https://t.co/o0xtoqbD6u; https://t.co/tkuMbmB3dZ. @BWHNeurology
In his new @statnews column “Neurotransmissions,” Jason Karlawish, MD, highlights how innovations in dementia diagnostics and treatments are transforming care and changing how society talks about dementia. https://t.co/EqWWJUqdBO…
Case Study 8: A 70-Year-Old Man With Memory Loss, Wandering, and Inappropriate Behaviors | The Journal of Neuropsychiatry and Clinical Neurosciences. @APAPubJournals https://t.co/IqqBX5fF9K
So much of Behavioral Neurology’s knowledge can be visualized through a data-driven, self-assembled graph of FDG-PET metabolic patterns across neurodegenerative and non-degenerative clinical diagnoses. 📊✨
#Neurology#FDGPET#BrainImaging#DataScience#Neurodegeneration#endalz
Think that the #brain contains circuits for "fight and flight"? Think again. Congratulations to @AlexFischbach_ et. al on a careful and groundbreaking study. @AffectiveSciLab#Neuroscience https://t.co/mT0hyYYXXd
Kenneth M. Heilman, a founder of the field of behavioral neurology who has died at 86, is remembered for impacting generations of young neurologists worldwide and serving @UFMedicine for over 50 years.
Read more: https://t.co/1WU2hGXRwK
A workgroup convened by @alzassociation has published revised criteria for the diagnosis & staging of Alzheimer’s disease, including updated biomarker classification and revised disease staging.
Read more at https://t.co/8HccPQgRGY
To coincide with the 100th anniversary of the publication of Ludwig Wittgenstein’s ‘Tractatus Logico-Philosophicus’, Andrew Larner considers the implications of philosophical themes in this and his other works for neurology and neuroscience. https://t.co/n4Kah6Zytz
@MphStanley There are so many wonderful poems and poets that have graced this green earth. On this day, I am recognizing Shel Silverstein, and this delightful poem and illustration from my childhood.
A free copy of “The Birth of the Clinic”, if anyone wants to revisit a masterpiece, and/or be inspired to translate this archaeology in to their world experiences.
https://t.co/MxWkbTqMFU
Special Communication describes the need for a systematic neurodegenerative disease framework for information collection and communication to standardize dementia nomenclature usage for research, clinical, and public health purposes. https://t.co/d3E0RllB9o
ANA Investigates the Clinical Implementation of Lecanemab for Alzheimer's Dementia podcast released! Listen to learn more about the clinical implementation of lecanemab, the anti-amyloid infusion therapy for Alzheimer's Disease. @SethGale @MeganRichieMD https://t.co/I5ksswWhwO
We are saddened to announce the passing of Galen V. Henderson, MD, FNCS, who served as Director of the @BWHNeuroICU in the Department of Neurology and Chief DEI Officer for @BrighamWomens. Our thoughts go out to his wife, Vanessa, his family, and his many friends.
Lecanemab is a big step forward for #Alzheimers patients and care partners. I enjoyed speaking to @MeganRichieMD about challenges / opportunities in our new world of treatments. ANA Investigates: https://t.co/wgZAlZympY @BWHNeurology @addiegmd @MassGenBrigham
This Ethics paper, Caregiver Burden and the Impact of Diagnostic Disclosure of Dementia: Why Primary Care Physicians have a Moral Responsibility to Disclose argues that both patient and caregiver have the right to be informed of the diagnosis https://t.co/kGV6vQ1d8D 3/
A case study that (hopefully) can help in highlighting the challenges of diagnosing #Alzheimer disease in older age, and differentiating it from LATE (and other entities); even with AD biomarkers. @anpadirect@BWHNeurology https://t.co/cNSXwTMLIj